227 related articles for article (PubMed ID: 28711446)
1. Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate in African-American Patients With Heart Failure.
Ziaeian B; Fonarow GC; Heidenreich PA
JACC Heart Fail; 2017 Sep; 5(9):632-639. PubMed ID: 28711446
[TBL] [Abstract][Full Text] [Related]
2. Use of hydralazine-isosorbide dinitrate combination in African American and other race/ethnic group patients with heart failure and reduced left ventricular ejection fraction.
Golwala HB; Thadani U; Liang L; Stavrakis S; Butler J; Yancy CW; Bhatt DL; Hernandez AF; Fonarow GC
J Am Heart Assoc; 2013 Aug; 2(4):e000214. PubMed ID: 23966379
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of hydralazine/isosorbide dinitrate in racial/ethnic subgroups with heart failure.
Hammermeister KE; Fairclough D; Emsermann CB; Hamman R; Ho M; Phibbs S; Plomondon M; Valuck R; West D; Steiner JF
Clin Ther; 2009 Mar; 31(3):632-43. PubMed ID: 19393854
[TBL] [Abstract][Full Text] [Related]
4. Use of isosorbide dinitrate and hydralazine in African-Americans with heart failure 9 years after the African-American Heart Failure Trial.
Ferdinand KC; Elkayam U; Mancini D; Ofili E; Piña I; Anand I; Feldman AM; McNamara D; Leggett C
Am J Cardiol; 2014 Jul; 114(1):151-9. PubMed ID: 24846808
[TBL] [Abstract][Full Text] [Related]
5. Clinical Effectiveness of Hydralazine-Isosorbide Dinitrate Therapy in Patients With Heart Failure and Reduced Ejection Fraction: Findings From the Get With The Guidelines-Heart Failure Registry.
Khazanie P; Liang L; Curtis LH; Butler J; Eapen ZJ; Heidenreich PA; Bhatt DL; Peterson ED; Yancy CW; Fonarow GC; Hernandez AF
Circ Heart Fail; 2016 Feb; 9(2):e002444. PubMed ID: 26867758
[TBL] [Abstract][Full Text] [Related]
6. Effects of ACE inhibitors or beta-blockers in patients treated with the fixed-dose combination of isosorbide dinitrate/hydralazine in the African-American Heart Failure Trial.
Ghali JK; Tam SW; Ferdinand KC; Lindenfeld J; Sabolinski ML; Taylor AL; Worcel M; Curry CL; Cohn JN;
Am J Cardiovasc Drugs; 2007; 7(5):373-80. PubMed ID: 18041162
[TBL] [Abstract][Full Text] [Related]
7. A review of isosorbide dinitrate and hydralazine in the management of heart failure in black patients, with a focus on a new fixed-dose combination.
Cheng JW
Clin Ther; 2006 May; 28(5):666-78. PubMed ID: 16861089
[TBL] [Abstract][Full Text] [Related]
8. Fixed-Dose Versus Off-Label Combination of Isosorbide Dinitrate Plus Hydralazine Hydrochloride: Retrospective Propensity-Matched Analysis in Black Medicare Patients with Heart Failure.
Ofili E; Anand I; Williams RA; Akinboboye O; Xu L; Puckrein G
Adv Ther; 2017 Aug; 34(8):1976-1988. PubMed ID: 28707284
[TBL] [Abstract][Full Text] [Related]
9. African-American Heart Failure Trial (A-HeFT): rationale, design, and methodology.
Franciosa JA; Taylor AL; Cohn JN; Yancy CW; Ziesche S; Olukotun A; Ofili E; Ferdinand K; Loscalzo J; Worcel M;
J Card Fail; 2002 Jun; 8(3):128-35. PubMed ID: 12140804
[TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation and mortality in African American patients with heart failure: results from the African American Heart Failure Trial (A-HeFT).
Mitchell JE; Tam SW; Trivedi K; Taylor AL; O'Neal W; Cohn JN; Worcel M
Am Heart J; 2011 Jul; 162(1):154-9. PubMed ID: 21742102
[TBL] [Abstract][Full Text] [Related]
11. Combination of Hydralazine and Isosorbide-Dinitrate in the Treatment of Patients with Heart Failure with Reduced Ejection Fraction.
Nyolczas N; Dékány M; Muk B; Szabó B
Adv Exp Med Biol; 2018; 1067():31-45. PubMed ID: 29086392
[TBL] [Abstract][Full Text] [Related]
12. Effects of nitrates and hydralazine in heart failure: clinical evidence before the african american heart failure trial.
Elkayam U; Bitar F
Am J Cardiol; 2005 Oct; 96(7B):37i-43i. PubMed ID: 16226934
[TBL] [Abstract][Full Text] [Related]
13. Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure Trial.
Chang KW; Beri N; Nguyen NH; Arbit B; Fox S; Mojaver S; Clopton P; Tam SW; Taylor AL; Cohn JN; Maisel AS; Anand IS
J Card Fail; 2018 May; 24(5):303-309. PubMed ID: 28918108
[TBL] [Abstract][Full Text] [Related]
14. The African American Heart Failure Trial: a clinical trial update.
Taylor AL
Am J Cardiol; 2005 Oct; 96(7B):44-8. PubMed ID: 16226935
[TBL] [Abstract][Full Text] [Related]
15. Isosorbide dinitrate/hydralazine: its role in the treatment of heart failure.
Thadani U; Jacob RG
Drugs Today (Barc); 2008 Dec; 44(12):925-37. PubMed ID: 19198701
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of fixed-dose combination of isosorbide dinitrate and hydralazine therapy for blacks with heart failure.
Angus DC; Linde-Zwirble WT; Tam SW; Ghali JK; Sabolinski ML; Villagra VG; Winkelmayer WC; Worcel M;
Circulation; 2005 Dec; 112(24):3745-53. PubMed ID: 16344404
[TBL] [Abstract][Full Text] [Related]
17. BiDil (isosorbide dinitrate and hydralazine): a new fixed-dose combination of two older medications for the treatment of heart failure in black patients.
Carmody MS; Anderson JR
Cardiol Rev; 2007; 15(1):46-53. PubMed ID: 17172884
[TBL] [Abstract][Full Text] [Related]
18. The African-American Heart Failure Trial: background, rationale and significance.
Taylor AL; Cohn JN; Worcel M; Franciosa JA;
J Natl Med Assoc; 2002 Sep; 94(9):762-9. PubMed ID: 12392039
[TBL] [Abstract][Full Text] [Related]
19. Effect of fixed-dose combination of isosorbide dinitrate and hydralazine on all hospitalizations and on 30-day readmission rates in patients with heart failure: results from the African-American Heart Failure Trial.
Anand IS; Win S; Rector TS; Cohn JN; Taylor AL
Circ Heart Fail; 2014 Sep; 7(5):759-65. PubMed ID: 24970468
[TBL] [Abstract][Full Text] [Related]
20. Isosorbide dinitrate and hydralazine in a fixed-dose combination produces further regression of left ventricular remodeling in a well-treated black population with heart failure: results from A-HeFT.
Cohn JN; Tam SW; Anand IS; Taylor AL; Sabolinski ML; Worcel M;
J Card Fail; 2007 Jun; 13(5):331-9. PubMed ID: 17602978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]